Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Sees Large Decrease in Short Interest

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) saw a large decline in short interest in December. As of December 15th, there was short interest totaling 4,335,942 shares, a decline of 36.3% from the November 30th total of 6,810,216 shares. Based on an average trading volume of 1,818 shares, the days-to-cover ratio is currently 2,385.0 days. Based on an average trading volume of 1,818 shares, the days-to-cover ratio is currently 2,385.0 days.

Genomma Lab Internacional Price Performance

Shares of OTCMKTS GNMLF remained flat at $1.06 during mid-day trading on Monday. The stock has a 50-day moving average price of $0.98 and a 200 day moving average price of $1.08. Genomma Lab Internacional has a one year low of $0.93 and a one year high of $1.43.

Genomma Lab Internacional Company Profile

Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.

The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.